AARTI PHARMALABS
|
The Current P/E Ratio of AARTI PHARMALABS is 28.15.
| Share Price | ₹752.6 | Jan 30,2026 |
| Market Cap | ₹6,818.1 Cr | |
| Earnings-TTM | ₹242.2 Cr | TTM-Consolidated Results |
| Price/Earnings | 28.15x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of AARTI PHARMALABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹6,818.1 Cr] as on Jan 30,2026
(/) Earnings [ ₹242.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 28.15x ]
Thus, for AARTI PHARMALABS , the investors are currently willing to pay 28.15 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AARTI PHARMALABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AARTI PHARMALABS over the last five years.
Historical PE (Price/Earnings) ratio chart of AARTI PHARMALABS
PE Ratio Performance Analysis for AARTI PHARMALABS
- AARTI PHARMALABS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 11.19x.
- AARTI PHARMALABS 's operated at median p/e ratio of 12.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AARTI PHARMALABS 's p/e ratio peaked in Mar2025 at 24.91x.
- AARTI PHARMALABS 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does AARTI PHARMALABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| AARTI PHARMALABS | 242.19 | 28.15 | 6,818.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 36.39 | 382,694.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 64.68 | 160,721.0 |
| CIPLA LTD | 4,544.70 | 23.53 | 106,946.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 62.62 | 134,016.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.46 | 101,691.0 |
| MANKIND PHARMA LTD | 1,767.06 | 49.64 | 87,717.0 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 17.91 | 89,071.8 |
| LUPIN LTD | 4,347.53 | 22.61 | 98,296.1 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.42 | 70,410.6 |
| ABBOTT INDIA LTD | 1,508.95 | 38.97 | 58,807.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AARTI PHARMALABS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.91x |
| Max industry PE | 64.68x |
| Median industry PE | 28.15x |
| Average industry PE | 34.85x |
You may also like the below Video Courses